HUP0004369A2 - Szubsztituált aminometil-kromán-származékok alkalmazása idegdegeneráció gátlására és idegregeneráció elősegítésére szolgáló gyógyszerkészítmények előállítására - Google Patents

Szubsztituált aminometil-kromán-származékok alkalmazása idegdegeneráció gátlására és idegregeneráció elősegítésére szolgáló gyógyszerkészítmények előállítására

Info

Publication number
HUP0004369A2
HUP0004369A2 HU0004369A HUP0004369A HUP0004369A2 HU P0004369 A2 HUP0004369 A2 HU P0004369A2 HU 0004369 A HU0004369 A HU 0004369A HU P0004369 A HUP0004369 A HU P0004369A HU P0004369 A2 HUP0004369 A2 HU P0004369A2
Authority
HU
Hungary
Prior art keywords
group
neural
substituted aminomethyl
chroman derivatives
promote
Prior art date
Application number
HU0004369A
Other languages
English (en)
Inventor
Thomas Fahrig
Irene Gerlach
Ervin Horváth
Reinhard Jork
Original Assignee
Bayer Ag.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag. filed Critical Bayer Ag.
Publication of HUP0004369A2 publication Critical patent/HUP0004369A2/hu
Publication of HUP0004369A3 publication Critical patent/HUP0004369A3/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

A találmány szerint alkalmazható szubsztituált amino-metil-kromán-származékok az (I) általános képletnek felelnek meg, amelyben R1 jelentése hidrogénatom, hidroxilcsoport vagy -OCH3, -OCH2CH3, -OCH(CH3)2 vagy -OCH2C(CH3)2-Cl képletű csoport, vagy R1 és R2 együttesen (a) képletű csoportot alkot, R3 jelentése ciklopentil-, ciklohexil-, cikloheptil- vagyciklooktilcsoport, vagy (b) képletű o-benzoszulfimidil-csoport, és n értéke 1, 2, 3, 4 vagy 5. A vegyületek agyi sérülések és azidegrendszer krónikus betegségei esetén elősegítik az idegekregenerálódását. Ó
HU0004369A 1997-11-24 1998-11-11 The use of substituted aminomethyl chroman derivatives for prevent neural degeneration and promote neural regeneration HUP0004369A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19751949A DE19751949A1 (de) 1997-11-24 1997-11-24 Verwendung von substituierten Aminomethyl-Chromanen zur Verhinderung der neuronalen Degeneration und zur Förderung der neuronalen Regeneration
PCT/EP1998/007197 WO1999026621A1 (de) 1997-11-24 1998-11-11 Verwendung von substituierten aminomethyl-chromanen zur verhinderung der neuronalen degeneration und zur förderung der neuronalen regeneration

Publications (2)

Publication Number Publication Date
HUP0004369A2 true HUP0004369A2 (hu) 2001-04-28
HUP0004369A3 HUP0004369A3 (en) 2002-04-29

Family

ID=7849618

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0004369A HUP0004369A3 (en) 1997-11-24 1998-11-11 The use of substituted aminomethyl chroman derivatives for prevent neural degeneration and promote neural regeneration

Country Status (30)

Country Link
US (2) US6235774B1 (hu)
EP (1) EP1051170B1 (hu)
JP (1) JP2001523716A (hu)
KR (1) KR20010032357A (hu)
CN (1) CN1134256C (hu)
AR (1) AR016973A1 (hu)
AT (1) ATE206615T1 (hu)
AU (1) AU745759B2 (hu)
BG (1) BG64167B1 (hu)
CA (1) CA2311126A1 (hu)
DE (2) DE19751949A1 (hu)
DK (1) DK1051170T3 (hu)
ES (1) ES2164465T3 (hu)
HN (1) HN1998000169A (hu)
HU (1) HUP0004369A3 (hu)
IL (1) IL135904A (hu)
IS (1) IS5496A (hu)
MY (1) MY118414A (hu)
NO (1) NO20002638D0 (hu)
NZ (1) NZ504656A (hu)
PE (1) PE134999A1 (hu)
PL (1) PL340674A1 (hu)
PT (1) PT1051170E (hu)
RU (1) RU2217140C2 (hu)
SI (1) SI1051170T1 (hu)
SV (1) SV1998000138A (hu)
TR (1) TR200001471T2 (hu)
TW (1) TW524690B (hu)
WO (1) WO1999026621A1 (hu)
ZA (1) ZA9810668B (hu)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19751949A1 (de) * 1997-11-24 1999-05-27 Bayer Ag Verwendung von substituierten Aminomethyl-Chromanen zur Verhinderung der neuronalen Degeneration und zur Förderung der neuronalen Regeneration
UA73981C2 (en) * 2000-03-10 2005-10-17 Merck Patent Gmbh (r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane for treatment of extrapyramidal movement disorders (variants), pharmaceutical composition and kit
US20030207890A1 (en) 2001-02-23 2003-11-06 Collier Robert J Compounds with 5-ht1a activity useful for treating disorders of the outer retina
EP1263434A1 (en) * 2000-03-17 2002-12-11 Alcon, Inc Compounds with 5-ht 2 and 5-ht 1a agonist activity for treating glaucoma
DE10058119A1 (de) * 2000-11-22 2002-05-23 Bayer Ag Pepinotan-Kit
SE0004455D0 (sv) * 2000-12-01 2000-12-01 Milos Pekny Method for neuron regeneration in the central nervous system
DE10101917A1 (de) * 2001-01-16 2002-07-18 Bayer Ag Verwendung von Chromanen
DK1408964T3 (da) * 2001-07-26 2007-05-21 Merck Patent Gmbh Hidtil ukendt anvendelse af 2-5-(4-fluorphenyl)-3-pyridylmethylaminomethyl-chroman og fysiologisk acceptable salte deraf
EP1425008B1 (en) * 2001-09-12 2006-10-04 MERCK PATENT GmbH Use of substituted aminomethyl chromans in the treatment of side effects of neuroleptics
DE10155075A1 (de) * 2001-11-09 2003-05-22 Merck Patent Gmbh Cyclische Sulfonamide
ITTO20030140U1 (it) * 2003-09-16 2005-03-17 Interfila Srl Matita cosmetica
CA2583087C (en) * 2003-09-19 2012-07-10 Galileo Pharmaceuticals, Inc. Chroman derivatives
DE102004017627A1 (de) * 2004-04-10 2005-10-27 Bayer Healthcare Ag Verwendung von vollen 5-HT1A-Agonisten zur Hemmung der opiat/opioid-induzierten Atemdepression
SG11201900687VA (en) 2016-07-29 2019-02-27 Sunovion Pharmaceuticals Inc Compounds and compositions and uses thereof
UA125519C2 (uk) 2016-07-29 2022-04-13 Суновіон Фармасьютікалз Інк. Сполуки і композиції і їх застосування
RU2651756C1 (ru) * 2017-05-10 2018-04-23 Федеральное государственное бюджетное образовательное учреждение Высшего Образования Кубанский Государственный Медицинский Университет Министерства Здравоохранения Российской Федерации, КубГМУ Препарат для предотвращения образования глиальных рубцов
CA3070993A1 (en) * 2017-08-02 2019-02-07 Sunovion Pharmaceuticals Inc. Isochroman compounds and uses thereof
AU2020236225A1 (en) 2019-03-14 2021-09-16 Sunovion Pharmaceuticals Inc. Salts of a isochromanyl compound and crystalline forms, processes for preparing, therapeutic uses, and pharmaceutical compositions thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5300523A (en) 1988-07-28 1994-04-05 Bayer Aktiengesellschaft Substituted aminomethyltetralins and their heterocyclic analogues
FR2662355B1 (fr) * 1990-05-22 1994-11-10 Sanofi Sa Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux.
DE4135474A1 (de) 1991-10-28 1993-04-29 Bayer Ag 2-aminomethyl-chromane
DE19522088A1 (de) 1995-06-19 1997-01-02 Bayer Ag Benzisothiazolyl-substituierte Aminomethylchromane
DE19751949A1 (de) * 1997-11-24 1999-05-27 Bayer Ag Verwendung von substituierten Aminomethyl-Chromanen zur Verhinderung der neuronalen Degeneration und zur Förderung der neuronalen Regeneration

Also Published As

Publication number Publication date
HN1998000169A (es) 1999-11-03
US6235774B1 (en) 2001-05-22
ZA9810668B (en) 1999-05-26
NO20002638L (no) 2000-05-23
IL135904A0 (en) 2001-05-20
RU2217140C2 (ru) 2003-11-27
CA2311126A1 (en) 1999-06-03
DE19751949A1 (de) 1999-05-27
AR016973A1 (es) 2001-08-01
IL135904A (en) 2003-07-06
WO1999026621A1 (de) 1999-06-03
AU1668599A (en) 1999-06-15
MY118414A (en) 2004-10-30
JP2001523716A (ja) 2001-11-27
SV1998000138A (es) 1999-05-25
AU745759B2 (en) 2002-03-28
CN1279604A (zh) 2001-01-10
EP1051170A1 (de) 2000-11-15
US20010018530A1 (en) 2001-08-30
SI1051170T1 (en) 2001-12-31
IS5496A (is) 2000-05-15
HUP0004369A3 (en) 2002-04-29
DK1051170T3 (da) 2001-12-27
US6331561B2 (en) 2001-12-18
ATE206615T1 (de) 2001-10-15
TR200001471T2 (tr) 2000-10-23
PL340674A1 (en) 2001-02-12
BG64167B1 (bg) 2004-03-31
DE59801724D1 (de) 2001-11-15
NZ504656A (en) 2002-02-01
ES2164465T3 (es) 2002-02-16
BG104466A (en) 2001-02-28
PT1051170E (pt) 2002-02-28
NO20002638D0 (no) 2000-05-23
PE134999A1 (es) 2000-03-05
TW524690B (en) 2003-03-21
EP1051170B1 (de) 2001-10-10
KR20010032357A (ko) 2001-04-16
CN1134256C (zh) 2004-01-14

Similar Documents

Publication Publication Date Title
HUP0004369A2 (hu) Szubsztituált aminometil-kromán-származékok alkalmazása idegdegeneráció gátlására és idegregeneráció elősegítésére szolgáló gyógyszerkészítmények előállítására
NO20025517D0 (no) Triazolderivater
FI961438A (fi) beta-amyloidiproteiinituotannon estäjiä
ATE374194T1 (de) Heteroarylsubstituierte triazolmodulatoren des metabotropen glutamatarezeptors 5
DK1303495T3 (da) Substituerede 5-alkylnylpyrimidiner med neurotrofisk aktivitet
MX9603479A (es) Derivados de 4-amino de acido micofenolico con actividad inmunosupresora.
ATE475418T1 (de) O-methylierte rapamycinderivate zur milderung oder vermeidung lymphoproliferativer erkrankungen
MXPA03010843A (es) Uso de derivados con azetidinona en el tratamiento de enfermedad de alzheimer.
DE69400799D1 (de) Verwendung von riluzol zur behandlung von parkinson und den parkinson-syndromen
DE68912419D1 (de) Verwendung von Uridin zur Behandlung nervöser Störungen.
MY120976A (en) 2-amino-6-(2-substituted-4-phenoxy)- substituted- pyridines
IL129178A0 (en) Induction of nerve generation
TR199800041T1 (xx) Heterosiklokarboksamid t�revleri ve tedavi i�in kullan�mlar�.
BG103687A (en) Atropisomers of 3-heteroaryl-4(3h)-quinazolinones for the treatment of neurodegenerative processes and conditions related to the central nervous system
ATE297396T1 (de) Neue atropisomere von 2,3-disubstituierten-(5,6)- heteroarylkondensierten-pyrimidin-4-onen
HUP0100611A2 (hu) Triazin vegyületek, és ilyeneket tartalmazó gyógyszerkészítmények a központi idegrendszer elváltozásainak kezelésére
ATE160143T1 (de) 2-substituierte morpholin- und thiomorpholinderivate als gaba-b antagonisten
NO953892D0 (no) Imidazolokinoksalinon-derivater som EAA-antagonister
DK0435177T3 (da) 4-Benzyl-5-phenyl-2,4-dihydro-3H-1,2,4-triazol-3-oner samt deres anvendelse som antikonvulsive midler
BR0016415A (pt) Inibidores de adenosina cinase para o tratamento de dano retinal e de nervo ótico
HUP0300566A2 (hu) Galantamin alkalmazása az Alzheimer-kórral összefüggő neuropszichiátriai viselkedésformák terápiájában
ATE268599T1 (de) Verwendung von beta-naphtaquinon derivaten zur herstellung eines arzneimittels mit einem hemmenden effekt auf die glutamatfreisetzung durch das gehirn
ES2140544T3 (es) Utilizacion de efaroxan y de sus derivados para la fabricacion de medicamentos destinados al tratamiento de las enfermedades neurodegenerativas.
HUP9701606A2 (hu) Szulbutiamin alkalmazása bizonyos pszichomotoros és pszichointellektuális rendellenességek kezelésére használható gyógyszerkészítmények előállítására
DE69310721T2 (de) Zuckerderivate von makroliden